Literature DB >> 12831163

Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain.

Ibolya G Farkas1, Andrea Czigner, Eszter Farkas, Endre Dobó, Katalin Soós, Botond Penke, Valéria Endrész, András Mihály.   

Abstract

Activated T-lymphocytes can migrate through the blood-brain barrier (BBB) and are able to invade the central nervous system (CNS). In the present study, we investigated whether disruption of the BBB leads to enhanced T-cell migration into the CNS. Amyloid-beta peptide 25-35 (A beta) or tumor necrosis factor-alpha (TNFalpha) were administered into the right common carotid artery of adult male Wistar rats. The agents were administered either alone, or were followed by a cell suspension of exogenously activated T-cells. Rats of other groups received activated or non-stimulated T-lymphocytes only. Sagittal brain sections were analyzed with immunohistochemistry of CD3 to reveal the presence of T-lymphocytes within the CNS parenchyma. Administration of activated T-cells alone led to T-cell migration into the brain. Infusion of either substances (A beta or TNFalpha) resulted in T-cell invasion of the CNS even when no exogenous T-cells were added. Infusion of either of the agents together with T-lymphocytes generated a more intense T-lymphocyte migration than in the other groups. Electron microscopic analysis and Evans-blue extravasation studies confirmed parallel disruption of the BBB. Our study demonstrates that A beta and TNFalpha induce enhanced T-lymphocyte migration towards the brain. This effect may be attributed at least partly to dysfunctioning of the BBB, but other mechanisms are also possible.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12831163     DOI: 10.1078/0065-1281-00696

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  19 in total

Review 1.  Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.

Authors:  Dharmini C Mehta; Jennifer L Short; Sarah N Hilmer; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2014-10-16       Impact factor: 4.200

Review 2.  Alzheimer's disease, brain immune privilege and memory: a hypothesis.

Authors:  Y I Arshavsky
Journal:  J Neural Transm (Vienna)       Date:  2006-08-24       Impact factor: 3.575

3.  Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

Authors:  J D Huber; C R Campos; K S Mark; T P Davis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-30       Impact factor: 4.733

4.  Resveratrol preserves cerebrovascular density and cognitive function in aging mice.

Authors:  Charlotte A Oomen; Eszter Farkas; Viktor Roman; Eline M van der Beek; Paul G M Luiten; Peter Meerlo
Journal:  Front Aging Neurosci       Date:  2009-12-09       Impact factor: 5.750

5.  Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells.

Authors:  Susan A Austin; Mary A Sens; Colin K Combs
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

6.  Soluble aggregates of the amyloid-beta protein selectively stimulate permeability in human brain microvascular endothelial monolayers.

Authors:  Francisco J Gonzalez-Velasquez; Joseph A Kotarek; Melissa A Moss
Journal:  J Neurochem       Date:  2008-09-16       Impact factor: 5.372

7.  Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.

Authors:  Sebastian Weckbach; Miriam Neher; Justin T Losacco; Ashley L Bolden; Liudmila Kulik; Michael A Flierl; Scott E Bell; V Michael Holers; Philip F Stahel
Journal:  J Neurotrauma       Date:  2012-04-10       Impact factor: 5.269

8.  Vascular endothelial barrier dysfunction mediated by amyloid-beta proteins.

Authors:  Enika Nagababu; Peter V Usatyuk; Divya Enika; Viswanathan Natarajan; Joseph M Rifkind
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.

Authors:  Gunjan D Manocha; Angela M Floden; Keiko Rausch; Joshua A Kulas; Brett A McGregor; Lalida Rojanathammanee; Kelley R Puig; Kendra L Puig; Sanjib Karki; Michael R Nichols; Diane C Darland; James E Porter; Colin K Combs
Journal:  J Neurosci       Date:  2016-08-10       Impact factor: 6.167

10.  Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Marzena U Amek
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.